Russias trials on personalized medicine treatments for cancer....BD
TUESDAY April 8, 2008 (foodconsumer.org) -- Antigenics' Oncophage treatment for kidney cancer patients was approved for use in Russia, according to news media reports.
The drug is intended for patients with medium risk of cancer relapse and the biotechnology company expects to put Oncophage on Russian market in the second half of 2008. Oncophage is a personalized medicine. It is made from each patient's tumor and contains the antigenic fingerprint of the patient's cancer. The drug is designed to reprogram the immune system to target cancer cells only.
0 comments :
Post a Comment